Airolign
A Smarter Balloon for Nasal Airway Realignment
Our Solution: Airolign
Airolign is a proprietary balloon-based device engineered to perform safe, consistent, and effective balloon septo-turbinatoplasty.
Using controlled insufflation pressure, Airolign gently realigns the nasal septum and laterally displaces (out-fractures) the inferior turbinates creating more space in the nasal airway.
Unlike prior ENT balloons, Airolign is optimized specifically for the septum and turbinate anatomy.
Its novel shape, pressure-regulated inflation system, and ease-of-use design enable ENT physicians to deliver a reproducible outcome with minimal patient discomfort.
What Makes Airolign Different
How It Works
-
Preparation
Local anesthesia is administered. The Airolign balloon is gently inserted into the nasal passage, aligning with the septum or turbinate area.
-
Controlled Inflation
The balloon is inflated to a pre-set pressure using the Airolign insufflation system, gently shifting and realigning the bony and cartilaginous structures.
-
Realigned Structure
The structures are gently repositioned, temporarily opening the airway by controlled balloon expansion.
-
Controlled Removal
The device is deflated and removed. No tissue is cut, no sutures required, and patients experience minimal downtime.
Indications for Use
Airolign is intended for patients suffering from:
-
Nasal airway obstruction due to septal deviation
Blocked airflow caused by a deviated septum.
-
Candidates for non-invasive or in-office treatment
Suitable for patients seeking quick, minimally invasive solutions.
-
Compensatory turbinate hypertrophy
Enlarged turbinates contributing to nasal blockage.
-
Chronic nasal congestion unresponsive to medical management
Persistent symptoms despite medication.
Benefits at a glance
No general anesthesia
Our approach eliminates the need for general anesthesia, making the procedure safer and easier for patients.
What’s Next
-
01
Concept & Prototype Development
Initial design and prototyping of Airolign’s patented trapezoidal balloon — engineered for safe, controlled septal realignment.
-
02
Preclinical Validation
Cadaveric and bench testing confirm precise septal correction, turbinate out-fracture, and consistent usability across cases.
-
03
Regulatory Alignment
FDA pre-submission completed with 510(k) pathway confirmed — streamlining the route to market approval.
-
04
Clinical Evaluation & Market Entry
Formative usability testing and early physician adoption begin, supported by training, data collection, and distributor partnerships.
-
05
Next-Gen AI Integration
Future phase introduces AI-guided pressure control and CT-based optimization — advancing Airolign from device to intelligent platform.
What Clinicians
& Advisors Are Saying
Trusted voices in ENT and MedTech are already recognizing the impact Airolign could have on nasal airway treatment. Here's what they’re saying:
M.S. Quaraishi
“From the cost and economics point of view, [Airolign] will be an amazing benefit both to the patient and to the hospital.”
Prof. Cem Meco
“[Airolign] will help us to help our patients in a very simple way, with little burden to them, achieving the same good results.”
Prof. Darlene E Lubbe
“I really love [Airolign]. We used it in a cadaveric specimen with a big septal spur. It beautifully fractured it… and created such a large airway.”
Dr. Camilo Van Strahlen
“You can use [Airolign] to do in-office procedures to widen the airway of an adult … instead of putting the patient through anethesia and the long waiting time for surgery.”
Prof. Iacopo Dallan
“[Airolign] could be a really good opportunity because it can add value to management of nasal obstruction and can add value to the patient.”
Prof. Isam Alobid
“[Airolign] leaves intact mucosa, no lacerations, and it’s more comfortable for the patient. I believe it is better for the patient and there will be no synechiae.”
Prof. Shawkat Abdulrahman
“[Airolign] is a very nice, simple device. Everything is designed by an experience rhinologist, and there is a great possibility to reduce any complications.”
Prof. Thibaut Van Zele
“I think the Airolign balloon is a minimally invasive tool for real, office-based rhinology procedures under local anesthetics.”
Sign Up for Early Access
Want to be among the first to evaluate Airolign? Join our early access program for clinicians, researchers, and healthcare partners.